107 results
8-K
EX-99.1
ADVM
Adverum Biotechnologies Inc
9 Nov 23
Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
4:07pm
compensation, material production and bioanalytics expenses, partially offset by higher facilities related expenses. Stock-based compensation expense included … to reversal of sublease income in prior year and lower compensation expense, partially offset by higher professional services expense. Stock-based compensation
8-K
EX-99.1
hdfvvlrkhku9qd8
10 Aug 23
Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results
4:09pm
8-K
EX-99.1
kbd0vbd2s399u
11 May 23
Adverum Biotechnologies Reports First Quarter 2023 Financial Results
4:10pm
8-K
EX-99.1
r1htsb
30 Mar 23
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Phase 2 LUNA Trial Update
4:09pm
8-K
EX-99.1
5atce4sv2 nkyefcnjq
10 Nov 22
Adverum Biotechnologies Reports Third Quarter 2022 Financial Results
4:14pm
8-K
EX-99.1
zwbp zj9p
12 May 22
Adverum Biotechnologies Reports First Quarter 2022 Financial Results
4:14pm
8-K
EX-99.1
q8ko2jde73l kzl2q
29 Mar 22
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2021 Financial Results
4:10pm